L. E. Bermudez, Inderlied, C. B., and Young, L. S.,
“Mycobacterium avium complex in AIDS.”,
Current clinical topics in infectious diseases, vol. 12, pp. 257-81, 1992.
C. B. Inderlied, Kemper, C. A., and Bermudez, L. E.,
“The Mycobacterium avium complex.”,
Clinical microbiology reviews, vol. 6, no. 3, pp. 266-310, 1993.
L. E. Bermudez, Danelishvili, L., and Early, J.,
“Mycobacteria and Macrophage Apoptosis: Complex Struggle for Survival.”,
Microbe Wash DC, vol. 1, no. 8, pp. 372-375, 2006.
L. S. Young, Bermudez, L. E., and Inderlied, C. B.,
“Mycobacteria and AIDS: treatment, prevention and future prospects.”,
Research in microbiology, vol. 143, no. 4, pp. 420-2, 1992.
L. S. Young, Gascon, R., Alam, S., and Bermudez, L. E.,
“Monoclonal antibodies for treatment of gram-negative infections.”,
Reviews of infectious diseases, vol. 11 Suppl 7, pp. S1564-71, 1989.
C. M. Whipps, Boorom, K., Bermudez, L. E., and Kent, M. L.,
“Molecular characterization of Blastocystis species in Oregon identifies multiple subtypes.”,
Parasitology research, vol. 106, no. 4, pp. 827-32, 2010.
L. E. Bermudez, Kolonoski, P., Petrofsky, M., Wu, M., Inderlied, C. B., and Young, L. S.,
“Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.”,
The Journal of infectious diseases, vol. 187, no. 12, pp. 1977-80, 2003.
L. E. Bermudez, Kolonoski, P., Wu, M., Aralar, P. A., Inderlied, C. B., and Young, L. S.,
“Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.”,
Antimicrobial agents and chemotherapy, vol. 43, no. 8, pp. 1870-4, 1999.
L. E. Bermudez, Wagner, D., and Sosnowska, D.,
“Mechanisms of Mycobacterium avium pathogenesis.”,
Archivum immunologiae et therapiae experimentalis, vol. 48, no. 6, pp. 521-7, 2000.